During the forecast period, the multiple myeloma diagnostics market is expected to grow at a promising CAGR of 10.3%. The market is currently worth US$ 13.62 billion and is expected to grow to US$ 32.91 billion by 2032. Multiple plasma cells aid in the fight against numerous illnesses, however the accumulation of malignant plasma cells …